Jazz Pharma upgraded at Goldman Sachs on outlook for op. margins - Seeking Alpha

Retrieved on: 2022-12-09 14:40:11

Tags for this article:

Click the tags to see associated articles and topics

Jazz Pharma upgraded at Goldman Sachs on outlook for op. margins - Seeking Alpha. View article details on hiswai:

Excerpt

Jazz Pharmaceuticals (JAZZ) traded higher pre-market Friday after Goldman Sachs upgraded the Ireland-based biopharma to Buy from Neutral.

Article found on: seekingalpha.com